Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system

Lu, WC; Sun, SS; Wei, JK; Thai, S; Li, DD; Tang, HL; Wang, TS; Sun, LL

Sun, LL (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Dept Pharm, Beijing, Peoples R China.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020; 42 (5): 1364

Abstract

Background A recent study is raising concerns that dipeptidyl peptidase 4 inhibitors are associated with increased risk of venous thromboembolism. Obj......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索